Capricor to Present Phase 3 HOPE-3 Data on Deramio...
Category : Clinical Trial Update 25 February 2026Capricor Therapeutics will deliver a late-breaking oral presentation of Phase 3 HOPE-3 data evaluati...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Neurent Medical Publishes Positive RCT Results for...
Category : Clinical Trial Update 25 February 2026Neurent Medical has published positive results from a randomized controlled trial (RCT) evaluating i...
European Commission Approves Lupin’s Biosimilar Ra...
Category : Approval/Launch 24 February 2026Lupin Limited has received approval from the European Commission for its biosimilar ranibizumab, Ran...
FDA Accepts Dr Reddy’s 351(k) BLA for Proposed Int...
Category : Approval/Launch 24 February 2026Dr. Reddy's Laboratories has announced that the U.S. Food and Drug Administration (FDA) has acce...
MGS Acquires Denmark’s Knudsen Plast to Expand Eur...
Category : Merger/Acquisition 24 February 2026Medtech contract manufacturer MGS has acquired Knudsen Plast A/S, a Denmark-based injection molder w...
Latest Newsletter Post
-
Neurent Medical Publishes Positive..
25 February 2026
-
Capricor to Present Phase 3 HOPE-3..
25 February 2026
-
Zepbound Outperforms CagriSema in H..
24 February 2026
-
MGS Acquires Denmark’s Knudsen Plas..
24 February 2026
-
FDA Accepts Dr Reddy’s 351(k) BLA f..
24 February 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com